Graft-versus-host disease (GVHD) remains a frequently occurring and difficult-to-treat complication in human allogeneic stem cell transplantation. Murine transplantation models are often used to study and understand the complex pathogenesis of GVHD and to explore new treatment strategies. Although GVHD kinetics may differ in murine and human models, adequate models are essential for identification of the crucial factors responsible for the major pathology in GVHD. We present a detailed description of the specific histological features of a graft-versus-host–induced fibrotic response in xenogeneic RAG2−/−γc−/− mice after total body irradiation and injection with human peripheral blood mononuclear cells. We describe the full morphological fea...
Objective To construct a mouse model of skin-dominant chronic graft-versus-host disease (cGVHD). Met...
AbstractChronic graft-versus-host-disease (cGVHD) is a major barrier to successful allogeneic hemato...
Despite considerable progress in allogeneic hematopoietic cell transplantation (allo-HCT) has been a...
Graft-versus-host disease (GVHD) remains a frequently occurring and difficult-to-treat complication ...
Chronic graft-versus-host disease (cGvHD) is the major source of late phase morbidity and mortality ...
The occurrence of Graft-versus-Host Disease (GvHD) is a prevalent and potentially lethal complicatio...
Morbidity and mortality are major concerns in graft-versus-host disease (GvHD), a response often see...
<div><p>Mice bearing a “humanized” immune system are valuable tools to experimentally manipulate hum...
<div><p>Chronic graft-versus-host disease (cGvHD) is the major source of late phase morbidity and mo...
The occurrence of Graft-versus-Host Disease (GvHD) is a prevalent and potentially lethal complicatio...
Mice bearing a "humanized" immune system are valuable tools to experimentally manipulate human cells...
AbstractChronic graft-versus-host disease (cGVHD) is a significant roadblock to long-term hematopoie...
Graft-versus-host disease (GVHD) remains a major complication of allogeneic hematopoietic cell trans...
Humanized mouse models can well be modified to study specific aspects of Graft-versus-Host Disease (...
Humanized mouse models can well be modified to study specific aspects of Graft-versus-Host Disease (...
Objective To construct a mouse model of skin-dominant chronic graft-versus-host disease (cGVHD). Met...
AbstractChronic graft-versus-host-disease (cGVHD) is a major barrier to successful allogeneic hemato...
Despite considerable progress in allogeneic hematopoietic cell transplantation (allo-HCT) has been a...
Graft-versus-host disease (GVHD) remains a frequently occurring and difficult-to-treat complication ...
Chronic graft-versus-host disease (cGvHD) is the major source of late phase morbidity and mortality ...
The occurrence of Graft-versus-Host Disease (GvHD) is a prevalent and potentially lethal complicatio...
Morbidity and mortality are major concerns in graft-versus-host disease (GvHD), a response often see...
<div><p>Mice bearing a “humanized” immune system are valuable tools to experimentally manipulate hum...
<div><p>Chronic graft-versus-host disease (cGvHD) is the major source of late phase morbidity and mo...
The occurrence of Graft-versus-Host Disease (GvHD) is a prevalent and potentially lethal complicatio...
Mice bearing a "humanized" immune system are valuable tools to experimentally manipulate human cells...
AbstractChronic graft-versus-host disease (cGVHD) is a significant roadblock to long-term hematopoie...
Graft-versus-host disease (GVHD) remains a major complication of allogeneic hematopoietic cell trans...
Humanized mouse models can well be modified to study specific aspects of Graft-versus-Host Disease (...
Humanized mouse models can well be modified to study specific aspects of Graft-versus-Host Disease (...
Objective To construct a mouse model of skin-dominant chronic graft-versus-host disease (cGVHD). Met...
AbstractChronic graft-versus-host-disease (cGVHD) is a major barrier to successful allogeneic hemato...
Despite considerable progress in allogeneic hematopoietic cell transplantation (allo-HCT) has been a...